Germany’s Health Ministry on Tuesday joined AstraZeneca in rubbishing reports quoting unnamed government sources that claimed the British-Swedish company’s Covid-19 vaccine showed little efficacy for people above 65.
Handelsblatt daily had reported on Monday that Berlin had estimated that the efficacy of the jab in people above 65 was just 8%, citing unnamed sources. Separately, Bild daily, quoting anonymous sources, put the efficacy rate at “less than 10%”.
But Germany’s Health Ministry said it appears that there have been some mix up in the reports.
“Around 8% of the volunteers in AstraZeneca’s efficacy studies were around 56 and 69 years old and three to 4% are above 70 years old,” said the Ministry.
“However, this does not mean that it is effective only in 8% of older people,” it added.
The company has also rejected the media reports on its vaccine efficacy in adults over 65 years as “completely incorrect”.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
